Tizaro
Category: Anti-biotics
Description:
Tirzepatide Is A GIP Receptor And GLP-1 Receptor Agonist. It Is A 39-amino-acid Modified Peptide With A C20 Fatty Diacid Moiety That Enables Albumin Binding And Prolongs The Half-life. It Selectively Binds To And Activates Both The GIP And GLP-1 Receptors, The Targets For Native GIP And GLP-1. It Enhances First And Second-phase Insulin Secretion And Reduces Glucagon Levels, Both In A Glucose Dependent Manner.
